Table 2. Absolute risks of major bleeding in selected patient sub groups (crude incidence rate per 1,000 patient-years, available case analysis).
Variable | Incidence rate (95% CI) |
---|---|
Overall | 10.6 (9.7–11.7) |
Age 80+ | 27.2 (21.1–35.0) |
Chronic kidney disease | 25.6 (20.8–31.6) |
Low bodyweight (< 60 kg) | 23.7 (17.3–32.4) |
Prior stroke | 18.9 (13.2–27.0) |
Diabetes mellitus | 16.8 (13.6–20.7) |
Prior CABG | 16.1 (12.0–21.7) |
Female sex | 14.9 (12.8–17.5) |
Stent length ≥ 40 mm | 13.0 (10.7–15.7) |
Number of stents ≥ 3 | 12.8 (10.3–15.9) |
Multivessel disease | 12.7 (11.1–14.5) |
Hypertension | 12.7 (11.1–14.5) |
Stent diameter < 3 mm | 12.0 (10.3–14.0) |
Prior MI | 11.9 (9.0–15.7) |
Current ACS | 10.6 (9.5–11.8) |
Hyperlipidemia | 10.4 (9.1–11.8) |
ACS: Acute coronary syndrome, CABG: Coronary artery bypass graft, CKD: Chronic kidney disease, MI: Myocardial infarction.